To keep up with the world’s rapidly aging population, the NAM launched the Healthy Longevity Global Competition, a multi-stage global competition designed to seek out bold, innovative, and breakthrough ideas that challenge the way we think about aging. The Catalyst Award, the first stage of the competition, rewards exciting opportunities that display prospective improvement in the mental, physical, and social well-being of individuals as they age. George Murphy is one of NAM’s 46 U.S.-based Catalyst Awardees. We hear from George, co-founder of the Boston University and Boston Medical Center’s Center for Regenerative Medicine (CReM), who speaks to the award-winning project seeking solutions in regenerative medicine to extend the human health span.
Latest publication from the Murphy Lab featured on the cover of Blood Advances: De Novo Hematopoiesis from the Fetal Lung!
Hemogenic endothelial cells (HECs) are specialized cells that undergo endothelial-to-hematopoietic transition (EHT) to give rise
